Oralni dodaci vitamina A za prevenciju akutnih infekcija gornjih dišnih puteva u djece do sedam godina Dosadašnje spoznaje Akutne infekcije gornjih dišnih puteva najčešće su akutne zarazne bolesti u djece, posebice djece predškolske dobi. Vitamin A ima pozitivnu ulogu u imunosnom sustavu i može poboljšati obranu domaćina od infekcija. Istraživanja pokazuju da djeca s nedostatkom vitamina češće pate od infekcija dišnog trakta. Stoga smo procijenili ulogu suplementacije vitamina A u prevenciji akutnih infekcija gornjih dišnih puteva u djece predškolske dobi (do sedam godina). Pitanje sustavnog...

Friday, May 10, 2024

Friday, May 10, 2024

Je li magnezijev sulfat za žene s rizikom od prijevremenog poroda bolji od placeba za zaštitu mozga njihovih beba? Ključne poruke Magnezijev sulfat koji se daje ženama s rizikom od prijevremenog poroda radi zaštite mozga njihovih beba smanjuje cerebralnu paralizu i kombinirani ishod smrti ili cerebralne paralize kod njihove djece do dvije godine starosti, u usporedbi s placebom. Buduća istraživanja u ovom području trebala bi se usredotočiti na učinke liječenja: • na djeci dok su adolescenti i odrasli; i • za različite skupine žena s rizikom od prijevremenog poroda, te s različitim načinima...

Pomaže li zajedničko donošenje odluka ženama pri donošenju odluke oko toga hoće li ili neće sudjelovati u probiru za rak dojke? Ključne poruke Zajedničko donošenje odluka bi moglo pomoći ženama da se osjećaju manje nesigurno ili žalosno te pomoći sa spoznajama tijekom procesa donošenja odluke o probiru raka dojke. Međutim, važno je napomenuti da je naše razumijevanje kako to točno može utjecati na odluke žena o probiru nepotpuno. Što znači zajedničko donošenje odluke? Zajedničko donošenje odluka je postupak u kojem liječnik i pacijent rade zajedno kako bi odabrali najbolju skrb. Razgovaraju...

Cink u prevenciji i liječenju prehlade Ključne poruke - Moguće je malo ili nikakvo smanjenje rizika od razvoja prehlade s dodacima cinka u usporedbi s placebom. - Za ljude koji su već prehlađeni, može doći do smanjenja trajanja prehlade uz upotrebu dodataka cinka u usporedbi s placebom. - Vjerojatno postoji povećanje rizika od lakših nuspojava kada se cink koristi za liječenje prehlade. Što je prehlada? Prehlada je prvenstveno virusna infekcija gornjih dišnih puteva. Ne postoji specifična kombinacija simptoma koja definira prehladu, ali simptomi mogu uključivati ​​začepljenost nosa, kihanje,...

We are delighted to announce the appointment of Dr Susan Phillips as the new Chair of Cochrane. Susan is Adjunct Associate Professor in the Faculty of Health Sciences & Medicine at Bond University, Queensland, Australia. She has held leadership positions in the field of evidence-based medicine since 2001 when she joined the Australian federal government’s newly established National Institute of Clinical Studies (NICS).

Susan is renowned for her achievements in translating research evidence into clinical practice. Her wealth of experience, gained from senior management roles at NICS where she became Interim Executive Director after the institute’s merger with Australia’s National Health and Medical Research Council, and later Chief Executive Officer at Therapeutic Guidelines Ltd, are testament to this. Her contribution to research translation was recognised with an Australia Day Medallion in 2008.

Susan’s extensive Board experience encompasses roles in organisations ranging from the Guidelines-International-Network (G-I-N), where she served as an elected Trustee for three terms, including two years as Vice-Chair, to Therapeutic Guidelines, and Therapeutic Guidelines Foundation. Susan has also served as Chair of other charities and not for profit organisations, including Climate for Change. She has been a Graduate of the Australian Institute of Company Directors (GAICD) since 2015.

In accepting this appointment, Dr Susan Phillips said: “I am deeply honoured to take on the role of Chair, especially during such a critical time for Cochrane when the need for trusted evidence to guide decisions about best treatments is greater than ever.”

Commenting on the appointment, Dr Tamara Kredo, Chair of the Governance and Nominations Committee, said “I am delighted that Dr Susan Phillips has been appointed Chair of Cochrane's Governing Board. Sue brings a wealth of experience and leadership qualities at an exciting time as we implement our new organizational strategy. I am sure you will all join me in expressing sincere thanks to Jordi Pardo Pardo who has served as Interim Chair of the Governing Board since September 2023. His commitment, hard work and enthusiasm have served the organisation well”.

Jordi will remain on the Governing Board until his term comes to an end later on this year.

Susan will take up the position as Chair in July 2024.

Tuesday, May 7, 2024

Kakvi su učinci antibiotika na bol i oteklinu uzrokovanu upalom ili infekcijom korijena zuba kod odraslih? Ključne poruke – Jedna doza antibiotika vjerojatno malo ili nimalo ne utječe na bol i oteklinu ako se uzima prije liječenja korijenskog kanala. – Dokazi o učinku antibiotika koji se uzimaju nakon debridmana (postupak koji uključuje djelomično ili potpuno čišćenje unutrašnjosti korijenskog kanala) na bol ili oteklinu vrlo su nesigurni. – Niti jedno istraživanje nije ispitalo učinak samih antibiotika, bez liječenja zuba, za ova dva stanja koja su obično odgovorna za uzrok zubobolje. Kako...

Postoji li najbolji način za uklanjanje mrtvog tkiva s kirurških rana? Ključna poruka Ne možemo biti sigurni hoće li uklanjanje mrtvog ili zaraženog tkiva s kirurških rana ili njega koja se obično pruža utjecati na to koliko je vremena potrebno da se ukloni svo mrtvo tkivo iz rane i da rana zacijeli. Što smo htjeli saznati? Nakon kirurškog zahvata većina kirurških rana prirodno zacjeljuje bez komplikacija. Međutim, može doći do komplikacija kao što je infekcija, što može dovesti do odgođenog zacjeljivanja. Postoji mnogo različitih metoda uklanjanja mrtvog ili zaraženog tkiva (što se naziva...

Mogu li lijekovi poput vareniklina i citizina (parcijalni agonisti nikotinskih receptora) pomoći ljudima da prestanu pušiti i uzrokuju li neželjene učinke? Ključne poruke · Vareniklin može pomoći ljudima da prestanu pušiti najmanje 6 mjeseci. Dokazi pokazuju da djeluje bolje od bupropiona i uporabe samo jedne vrste nikotinske nadomjesne terapije (npr. samo flastera). Stope prestanka pušenja mogu biti slične uporabi više od jedne vrste nikotinske nadomjesne terapije u isto vrijeme (npr. flasteri i žvakaća guma zajedno). · Citizin može pomoći ljudima da prestanu pušiti najmanje 6 mjeseci....

Title: Legal Officer/Junior Legal Counsel
Specifications: Permanent – Part time (30 hours a week)
Salary: £38,000 per annum
Location: UK (Remote with occasional travel to the London office)
Closing date:  17 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, Chief Executive Office and Finance and Corporate Services.

This role will sit within the Legal Team in Cochrane’s Finance & Corporate Services Directorate, which also includes the Finance and HR teams.

The Legal Officer/ Junior Legal Counsel will be required to support the Legal Counsel in providing legal advice to colleagues across the organisation, to enable Cochrane to manage risk and meet its legal and regulatory obligations. In addition to experience in contract law, the successful candidate will have excellent communication and organisational skills, a self-motivated and proactive approach to their work, and an enthusiasm for developing their knowledge and skills.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

• Collaboration: Underpins everything we do, locally and globally.
• Relevant: The right evidence at the right time in the right format.
• Integrity: Independent and transparent.
• Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• Further information on the role and how to apply
• The deadline to receive your application is 17 May, 2024.
• The supporting statement should indicate why you are applying for the post and how far you meet the requirements, using specific examples. 
•        Read our Recruitment Privacy Statement

Friday, May 3, 2024 Category: Jobs

Title: Legal Counsel
Specifications: Permanent – Full time or part-time (4-5 days per week)
Salary: £59,000 per annum
Location: Remote working (UK office located in Central London)
Closing date:  17 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, Chief Executive Office and Finance and Corporate Services.

The Legal Counsel will be required to provide legal advice to colleagues across the organisation, to enable Cochrane to manage risk and meet its legal and regulatory obligations. The successful candidate will have excellent communication and organisational skills, a pragmatic approach, and the ability to prioritise and manage an unpredictable workload whilst paying close attention to detail.

The role will include line managing the Junior Legal Counsel, a role which we are also currently recruiting for.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

Collaboration: Underpins everything we do, locally and globally.
Relevant: The right evidence at the right time in the right format.
Integrity: Independent and transparent.
Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• Further information on the role and how to apply
• The deadline to receive your application is 17 May, 2024
• The supporting statement should indicate why you are applying for the post and how far you meet the requirements, using specific examples. 
• Read our Recruitment Privacy Statement

Friday, May 3, 2024 Category: Jobs

Thursday, May 2, 2024

Thursday, May 2, 2024

Smanjuje li cijepljenje trudnica protiv respiratornog sincicijskog virusa (RSV) hospitalizacije dojenčadi povezane s RSV-om? Ključne poruke • Istraživanja u ovom sustavnom pregledu ukazuju na to da cijepljenje protiv respiratornog sincicijskog virusa (RSV) tijekom trudnoće smanjuje hospitalizacije dojenčadi povezane s RSV-om. • Rezultati ukazuju na to da cijepljenje protiv RSV-a tijekom trudnoće ima mali ili nikakav učinak na rizik od urođenih mana u dojenčadi i vjerojatno ima mali ili nikakav učinak na rizik od ograničenja rasta fetusa. • Buduća istraživanja u ovom području trebala bi se...

Metformin za hiperplaziju endometrija Istraživačko pitanje Je li metformin učinkovit i siguran način liječenja za žene s hiperplazijom endometrija? Dosadašnje spoznaje Rak endometrija (rak sluznice maternice) čest je rak koji zahvaća reproduktivne organe žena diljem svijeta. Hiperplazija endometrija (zadebljanje sluznice maternice) prekancerozno je stanje kod žena koje može dovesti do raka endometrija ako se ne liječi. Uspješno liječenje žena s hiperplazijom endometrija može spriječiti rak endometrija. Hiperplazija endometrija obično se liječi davanjem tableta hormona progesterona, umetanjem...

Location: Flexible location (remote working) – contract type dependent on location.
Specifications: Permanent employment contract if successful applicant based in UK, Germany or Denmark. Consultancy contract in other locations.
Salary: £48,000 per annum
Application Closing Date:  7 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into four directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Consumer Engagement Manager will work as part of Cochrane’s Development Directorate, supporting the production of best evidence for healthcare by contributing to the implementation of Cochrane strategy and priorities relating to consumer engagement and involvement. This will be achieved through developing and maintaining a diverse global consumer community; supporting and facilitating consumer involvement in the broadest possible range of Cochrane activities; disseminating Cochrane evidence; supporting consumer involvement in Cochrane governance; building partnerships with relevant organisation; developing methods to improve the practice of engagement and involvement in systematic reviews, in the governance of the organisation, and in conferences and other settings; contributing to strategies to evaluate the impact of consumer engagement in systematic reviews; and contributing to the development of fundraising and project activity.
      
Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

Collaboration: Underpins everything we do, locally and globally.
Relevant: The right evidence at the right time in the right format.
Integrity: Independent and transparent.
Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• For further information on the role and how to apply, please click here.  
• The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples. Note that we will assess applications as they are received, and therefore may fill the post before the deadline.
• Deadline for applications: 7 May 2024 (12 midnight GMT).
• Read our Recruitment Privacy Statement
   

Wednesday, April 24, 2024 Category: Jobs

Cochrane, JBI, Guidelines International Network (GIN), and The Campbell Collaboration are hosting the second Global Evidence Summit (GES) in the historic city of Prague from 10 to 13 September 2024. The summit serves as a platform for professionals from diverse sectors, including health, education, social justice, environment, and climate change, to engage in crucial discussions aimed at informing policy and practice through evidence. As part of the GES experience, attendees are invited to participate in the Anne Anderson Walk, an event that combines sightseeing, social engagement, and philanthropy. 

Anne Anderson was a reproductive physiologist,  researcher, lecturer, and author. She was a contributor to the stream of thinking and effort that gave birth to evidence-based health care.  Her inclusion in Lifeology's Historic STEAM Heros shows her lasting influence. Each year, a walk is held in her honour. Participants make donations to support the Anne Anderson Award, which recognizes and stimulates individuals contributing to the enhancement of women’s visibility and participation in leadership.



Everyone attending GES is welcome to join the  Anne Anderson Walk. It will be a gentle stroll on mostly flat surfaces and is wheelchair accessible. It is approximately 1.3 km long and will take about 50 minutes. The walk is free but participants are encouraged to make a donation to the Anne Anderson Award. This self-guided walk takes you a scenic journey through Prague's historic landmarks, including the renowned Old Town Square, the medieval astronomical clock, and the Bohemian Bridge. The walk concludes at the Vltava river, where attendees can continue their exploration with an optional boat cruise.

• Wednesday 11 September 2024 at 6pm where we will have a volunteer tour guide so that you can end with an optional boat cruise
• Make a donation to the Anne Anderson Award in advance
• Anne Anderson Walk merchandise is available to purchase in advance
  

Join us for an unforgettable experience at the Global Evidence Summit 2024 and the Anne Anderson Walk. Let's come together to celebrate the power of evidence-based practice and honour the remarkable legacy of Anne Anderson. Register now by donating to the Anne Anderson Award, and mark your calendar for the walk. We can't wait to walk alongside you in Prague!

• Register for the walk by making a donation
• Cochrane members are invited to make a nomination for the Anne Anderson Award
• Learn more about the Global Evidence Summit

Thursday, August 1, 2024

Sprječava li puštanje komaraca koji prenose Wolbachiju infekciju denga groznicom? Ključne poruke – Ljudi koji žive u područjima gdje su pušteni komarci Aedes koji prenose Wolbachiju imaju manju vjerojatnost da će se zaraziti denga groznicom od ljudi koji žive u područjima gdje takvi komarci nisu pušteni. – Ljudi koji žive u područjima gdje su pušteni Aedes komarci koji prenose Wolbachia bakteriju imaju manju vjerojatnost da će biti primljeni u bolnicu zbog denga groznice nego ljudi koji žive u područjima gdje takvi komarci nisu pušteni. Što je denga groznica? Denga je virusna bolest koju...

Thursday, April 18, 2024